RNA-Targeted Drug Discovery Summit returns for its fifth year this December. Join the summit for deep dive into new and emerging topics such as:
- Induced Proximity as a new class of “targeted RNA degraders”
- Next-generation probing and screening technologies to accelerate HIT identification and validation
- Biophysical, biochemical, and cell-based assay development strategies to identify and optimize small molecules interacting with RNA
- In vivo pharmacology, safety, and efficacy early considerations to accelerate the transition from discovery to pre-clinical and clinical development
View the event program here: https://ter.li/7qs017
Secure your place here: https://ter.li/jlh128
If you have any further questions regarding the summit, please contact us at info@hansonwade.com.